
Financing - March 16, 2020
iCellate Medical and Elthera receives 25 million SEK grant
Swedish iCellate Medical has together with the Swiss biopharmaceutical company Elthera (and consortium) received a grant of 25 MSEK from Eurostars to develop a new second generation immunotherapy drug for pancreatic and ovarian cancers. In the evaluation process Eurostars rated iCellate’s project as the most interesting among all Swedish applicants, states the company in its […]